[LDL-c and residual cardiovascular risk in patients with coronary artery disease].
In secondary prevention, current therapeutic management of dyslipidemia primarily aims to reduce low-density lipoprotein cholesterol (LDL-c) levels, as LDL-c is a major driver of atherosclerosis. Elevated LDL-c levels are also one of the main modifiable cardiovascular risk factors. LDL-c lowering is directly, proportio...